02500.HK
Venus Medtech (Hangzhou) Inc.
HKSE · Healthcare · Medical - Devices · CN
HKD 1.22
+3.83%Year over year
Reported trailing growth
- Revenue
- -25.7%
- EBITDA
- +21.7%
- EBIT
- +46.4%
- EPS
- +37.4%
- Free cash flow
- +75.2%
- Operating cash flow
- +67.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -9.0%
- EBITDA
- +48.5%
- EBIT
- +0.4%
- Net income
- +42.9%
- EPS
- +42.9%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026